Besivance is indicated for the treatment of bacterial conjunctivitis in patients aged ≥1 year whose infection is caused by susceptible isolates of the following bacteria: CDC coryneform group G, Corynebacterium pseudodiphtheriticum, Corynebacterium striatum, Haemophilus influenzae, Moraxella lacunata, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus hominis, Staphylococcus lugdunensis, Streptococcus mitis group, Streptococcus oralis, Streptococcus pneumoniae, and Streptococcus salivarius.
Besivance适用于治疗年龄≥1 岁、由下列细菌的致病分离物所致的细菌性结膜炎患者：CDC棒状杆菌G群，假白喉棒杆菌，纹带棒杆菌，流感嗜血杆菌，腔隙莫拉菌，金黄色葡萄球菌，表皮葡萄球菌，人葡萄球菌，路邓葡萄球菌，缓症链球菌群，口腔链球菌，肺炎链球菌以及唾液链球菌。